GSEA analyses revealed that the treatment of both cell lines increased the expression of apoptosis and p53 pathway-related genes while suppressing the genes associated with the E2F target, G2M checkpoint, oxidative phosphorylation, and MYC target mechanism, indicating a directly proportional relationship with the antiproliferative effect on cancer cells and increased apoptosis. This evidence concerns the gene TP53 and cancer.